Delivery Order SPE2DB24D9113-SPE2DB25FEPZR
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,559.48 firm fixed-price delivery order is for the provision of MENQUADFI VIAL 0.5ML pharmaceutical products to the DLA. The award is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract, SPE2DB, which enables the DLA to issue delivery orders for a wide range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order valued at $1,559.06. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a specialized pharmaceutical product, with a performance period through February 13, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $11,692.95, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is the prime contractor and holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,559.06 firm fixed-price delivery order is for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a period of performance through February 13, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,500.30, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,897.65, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The award has an ultimate completion date of May 1, 2025 and was made on April 30, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,559.06, is a delivery order for the supply of medical products including 4568122848 MENQUADFI VIAL 0.5ML. The contract is a firm fixed-price delivery order without a set-aside designation, awarded under a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. This...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,559.06 contract is for the delivery of 4568025978 MENQUADFI VIAL 0.5ML medical supplies. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award, valued at $1,559.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of "MENQUADFI VIAL 0.5ML" medical products, with an ultimate completion date of March 26, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,338.59 contract is for the delivery of MENQUADFI VIAL 0.5ML medication, with a period of performance through November 2024. DMS Pharmaceutical Group holds a large single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid...